Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia

IntroductionInduction intravesical Bacillus Calmette-Guerin (BCG) followed by maintenance after transurethral resection of bladder tumor, is the standard adjuvant therapy for high-risk non-muscle invasive bladder cancer (NMIBC). There is sparse evidence on the practice of intravesical BCG in Austral...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Frontiers in Urology
المؤلفون الرئيسيون: Chamodi Pillippu Hewa, Stephen Della-Fiorentina, Kayvan Haghighi, Wei Chua, Peey-Sei Kok
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Frontiers Media S.A. 2024-02-01
الموضوعات:
intravesical BCG
NMIBC
disease-free survival
bladder cancer
TURBT
overall survival
الوصول للمادة أونلاين:https://www.frontiersin.org/articles/10.3389/fruro.2024.1309532/full

الانترنت

https://www.frontiersin.org/articles/10.3389/fruro.2024.1309532/full

مواد مشابهة